Clinical Predictors and Outcomes of Invasive Anal Cancer for People With HIV in an Inception Cohort
Clinical Infectious Diseases · 2024
DOI: 10.1093/cid/ciae124 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2024. Verfasst von Edward R Cachay und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Owen Clinic, UC San Diego, San Diego, California, USA. Hauptthemen laut MEDLINE: Anus Neoplasms, HIV Infections. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIH, University of California San Diego Center for AIDS Research.
Abstract (Originalsprache)
Background
Due to the heterogeneity of risk for invasive anal cancer (IAC) among people with human immunodeficiency virus (PWH), we investigated predictors of IAC and described outcomes among those with a cancer diagnosis.
Methods
Using a longitudinal inception cohort of anal cancer screening, we evaluated risk factors and outcome probabilities for incident IAC in Cox models. Screening included anal cytology and digital anorectal examination, and, if results of either were abnormal, high-resolution anoscopy.
Results
Between 30 November 2006 and 3 March 2021, a total of 8139 PWH received care at the University of California, San Diego, with 4105 individuals undergoing screening and subsequently followed up over a median of 5.5 years. Anal cancer developed in 33 of them. IAC was more likely to develop in patients with anal high-grade squamous intraepithelial lesions (aHSILs) on initial or subsequent follow-up cytology (hazard ratio, 4.54) and a nadir CD4 cell count ≤200/µL (2.99). The joint effect of aHSILs and nadir CD4 cell count ≤200/µL amplified the hazard of IAC by 9-fold compared with the absence of both. PWH with time-updated cytology aHSIL and CD4 cell counts ≤200/µL had 5- and 10-year probabilities of IAC of 3.40% and 4.27%, respectively. Twelve individuals with cancer died, 7 (21% of the total 33) due to cancer progression, and they had clinical stage IIIA or higher cancer at initial diagnosis.
Conclusions
PWH with both aHSIL and a nadir CD4 cell count ≤200/µL have the highest risk of IAC. PWH who died due to IAC progression had clinical stage IIIA cancer or higher at diagnosis, highlighting the importance of early diagnosis through high-resolution anoscopic screening.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Owen Clinic, UC San Diego, San Diego, California, USA.
- Department of Medicine, Division of Infectious Diseases and Global Public Health, UC San Diego, San Diego, California, USA.
ORCID-Profile: Edward R Cachay
Förderung
- NIAID NIH HHS
- NIH
- University of California San Diego Center for AIDS Research
- Pacific AIDS Education and Training Center
Zitieren
APA
Cachay, E. R., Gilbert, T., Qin, H., & Mathews, W. C. (2024). Clinical Predictors and Outcomes of Invasive Anal Cancer for People With HIV in an Inception Cohort. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciae124
Vancouver
Cachay ER, Gilbert T, Qin H, Mathews WC. Clinical Predictors and Outcomes of Invasive Anal Cancer for People With HIV in an Inception Cohort. Clinical Infectious Diseases. 2024. doi:10.1093/cid/ciae124
BibTeX
@article{Cachay2024,
author = {Cachay, Edward R and Gilbert, Tari and Qin, Huifang and Mathews, Wm Christopher},
title = {Clinical Predictors and Outcomes of Invasive Anal Cancer for People With HIV in an Inception Cohort},
journal = {Clinical Infectious Diseases},
year = {2024},
doi = {10.1093/cid/ciae124}
}
EUVIMED